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Introduction
Internal organs participate in and sustain all types of  
activity for life. Many factors, such as acute ischemia, 
anoxia, and inflammatory factors, may induce multi-tissue 
damage in some internal organs after severe burn injury. 
Tissue damage in these internal organs has proven to be 
responsible for aggravation of  disease, the development of  
complications, and increased mortality. Better prevention 
and timely rehabilitation and reconstruction of  those 
important internal organs are critical for improving survival 
A b s t r A c t
Mitsugumin 53 (MG53), a newly identified muscle-specific protein, is an essential component of the cell membrane repair machinery 
in skeletal and cardiac muscle. However, the role of MG53 after burns in other tissues remains unclear. This study aims to investigate 
the possible roles of MG53 in the protection of the kidney after severe burn injury, and an animal scalding model of 30% of total body 
surface area (TBSA) was used. Recombinant human MG53 (rhMG53) or bovine serum albumin (BSA) was injected intravenously via 
the tail vein. Data showed that the mortality in the MG53-treated group was lower than that in control group. Administration of 
rhMG53 may alleviate histological alterations in renal tubular epithelial cells after burn injury. Renal tubular injury scores and the 
average optical density score of kidney injury molecule-1 (KIM-1) immunohistochemical staining in the MG53-treated group were 
significantly lower than those in control group (P < 0.001). Exogenous rhMG53 was found to be located in renal tubular epithelial 
cells. Numerous polymerase I and transcript release factor (PTRF) were expressed in the mouse kidney after severe scalding. In 
conclusion, our data indicate that MG53 protein protects the kidney by involving local PTRF after severe burn injury.
Key words: Burn injury, recombinant human Mitsugumin53, kidney, polymerase I and transcript release factor, kidney injury 
molecule-1
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and reducing mortality. After severe scalding, the ischemic 
injury that occurs in the organs and the repair process does 
not attract public attention due to the lack of  macroscopic 
evidence, the wide range of  effects, the number of  organs 
involved, its complex/concealed pathogenesis, and the 
ineffective repair-promoting measures used.[1] In the 
past, various measures were taken that targeted certain 
stages of  pathogenesis or alleviated the degree of  injury; 
however, they did not repair cells directly. Thus, they did 
not contribute to the initiation of  organ repair. Therefore, 
investigating how to accelerate and enhance the initial 
repair of  injured organs has become critical for successfully 
rescuing severely scalded patients and to prevent/treat 
the	multiple	 organ	dysfunction	 syndrome	 (MODS)	 and	
multiple	system	organ	failure	(MSOF)	that	occur	later.	It	
is an important research topic in medicine and is of  great 
theoretical/clinical significance.
Mitsugumin 53 (MG53), a muscle-specific tripartite motif  
(TRIM) family protein, is an essential component of  
the cell membrane repair machinery. Ma et al., reported 
that recombinant human MG53 (rhMG53) may show 
therapeutic action against Duchenne muscular dystrophy 
as well as other human diseases that involve membrane 
injuries. The rhMG53 protein can recognize the external 
signals at the injured membrane sites and increase 
membrane resealing in cultured muscle and non-muscle 
cells when added to the culture medium. Animal studies 
have shown that application of  rhMG53 via multiple routes 
(intramuscular, intravenous, or subcutaneous) improves 
the membrane repair capacity of  skeletal myocytes and 
ameliorated muscular dystrophy.[2]
Therefore, it is reasonable to propose that exogenous 
rhMG53 may promote the recovery of  damaged cells and 
repair of  injured cell membranes in a burn model. Here, we 
report the possible roles of  rhMG53 in the prevention of  
internal organ tissue injury and that it may reduce mortality 
in a mouse severe burn model.
Materials and Methods
Animals
Male BALB/c mice, weighing between 19 and 21 g, were 
provided by the Animal Center of the Third Military Medical 
University of China. These mice were maintained behind a 
barrier and were provided with plenty of food and water.
Reagents
Kidney injury molecule-1 (KIM-1) antibody was purchased 
from Abcam, Cambridge, England). MG53 antibody 
was presented by Professor Ma Jianji, the Laboratory of  
UMDNJ-Robert Wood Johnson Medical School, Newark, 
New Jersey, USA. Polymerase I and transcript release 
factor (PTRF) antibodies were purchased from Proteintech 
Group, Chicago, Illinois, USA. Antigen retrieval buffers were 
purchased from Wuhan Boster Bio-engineering Co. Ltd. Goat 
serum, goat anti-rabbit secondary antibody, and horseradish 
peroxidase-labeled streptavidin were purchased from Beijing 
Zhong Shan Golden Bridge Bio-technology Co. Ltd.
Burn model
Briefly, the dorsal part of  the mouse was shaved. Mice were 
anesthetized with 1% amobarbital at a dose of  40 mg/kg, 
and the shaved part of  the skin was burnt using a constant-
temperature/pressure electric scalding device at 90°C for 
8 s with 0.5 kg pressure, which induced a 30% total body 
surface area (TBSA) and full thickness burn injury, which 
was confirmed histologically. Immediately after the burn, 
a total of  2.5 ml of  lactate-linger solution was injected 
intraperitoneally to treat for shock.[3,4]
Test groups and method of administration
A total of  16 severely scalded mice were divided randomly 
into control group and MG53-treated group (MG53 group) 
with eight mice in each group. For the rhMG53-treated 
group, rhMG53 was injected twice into the tail vein at 
0.5 and 6.5 h after scalding at 3 mg/kg,[2] and for the 
control group, a dose of  bovine serum albumin (BSA) was 
administered.
Mortality evaluation
The mortality of  mice was recorded every 6 h within the 
48 h after scalding.
Tissue sample preparation and histopathological observation
At 48 h after the scalding, mice were anesthetized with 1% 
amobarbital and perfused via the left ventricle with 20 ml 
of  a 4% paraformaldehyde solution. The heart, liver, spleen, 
lung, kidney, stomach, small intestine, colon, skin, muscle, 
and brain were then removed. All tissues were fixed in 
4% paraformaldehyde solution, followed by dehydration, 
hyalinization, paraffin-embedding, and sectioning at 5 mm. 
All sections were stained with hematoxylin and eosin (HE) 
and observed under a microscope.
Pathological scoring of the renal tubule for degree of 
necrosis
To measure the pathological score, 20 visual fields from 
each section were selected randomly under the microscope 
and were scored using a semiquantitative pathological 
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assessment method (Erdogan et al.,) based on the degree 
of  necrosis of  the renal tubules.[5] Briefly, 0 denotes 
normal kidney morphology, 1 denotes rare necrosis 
(necrosis of  <5% of  renal tubules), 2 denotes mild 
necrosis (necrosis of  5-25% of  renal tubules), 3 denotes 
moderate necrosis (necrosis of  25-75% of  renal tubules), 
and 4 denotes severe necrosis (necrosis of  >75% of  renal 
tubules).
Immunohistochemical staining
Antibodies targeted against KIM-1, MG53, and PTRF 
were obtained. Briefly, kidney paraffin-embedded sections 
were deparaffinized and then hydrated. The sections were 




 to deactivate endogenous 
peroxidases, followed by antigen retrieval, blocking with 
normal goat serum, and incubation with primary antibodies 
as follows: 1:100 KIM-1[6] polyclonal antibody, 1:100 
rabbit anti-human MG53 antibody,[7] and 1:100 rabbit 
anti-human PTRF antibody. Sections were then incubated 
with goat anti-rabbit secondary antibody followed by 
horseradish peroxidase-labeled streptavidin. The sections 
were developed, stained with hematoxylin and observed 
under a microscope. Five fields were selected from each 
section at random, and photomicrographs were taken and 
analyzed semiquantitatively using Integrated Performance 
Primitives (IPP) software.
Statistical analyses
Results are expressed as the mean ± standard deviation 
(x– ± sd) and were analyzed using t-tests, Chi-squared tests, 
and Kaplan-Meier tests using Statistical Package for Social 
Sciences (SPSS) software and Microsoft Excel. A P-value 
of  <0.05 was considered statistically significant.
Results
The role of rhMG53 in mortality of burn mice
The mortality at 24 h after burn injury was 12.5% in the 
MG53-treated group and 12.5% in the control group. At 
48 h after burn injury, 25% of  the MG53-treated group 
and 37.5% of  the control group had died. However, there 
was no significant difference between the two groups at 
the time intervals tested although the MG53-treated group 
showed slightly less mortality than the control group 
[Figure 1] (P = 0.681).
The effect of rhMG53 on histological alterations in 
internal organs
In the MG53-treated group, the epithelial cells of  the 
proximal and distal convoluted renal tubules were improved 
significantly with respect to cloudy swelling and degeneration. 
In addition, less inflammatory cells were present in the renal 
mesenchyma in the MG53-treated group than in the control 
group. However, there was no significant improvement in 
renal glomerular area [Figure 2a, b, and c]. Moreover, the 
semiquantitative pathological score of  the MG53-treated 
group was significantly lower than that of  the control group 
[Figure 2d] (P < 0.001) at 48 h after scalding. However, HE-
stained tissue sections from the heart, liver, spleen, lung, 
stomach, small intestine, colon, skin, muscle, and brain did 
not show differences between the MG53-treated group and 
control group.
The expression of both KIM-1 and PTRF in kidney
KIM-1 positive cells were noted in the renal tissues of  both 
groups [Figure 3a]; however, the average optical density 
score in the MG53-treated group was significantly lower 
than that in the control group [Figure 3b] (P < 0.001). 
PTRF-positive cells were observed in the renal tissues of  
both groups [Figure 4a]. No significant difference in mean 
optical density score was observed between the MG53-
treated and control groups [Figure 4b] (P = 0.890).
The distribution of exogenous rhMG53 in internal organs
Based on the immunohistochemical data, numerous MG53+ 
cells were noted in the cardiac/skeletal muscles of  both 
groups but not in other organs of  the control group. In 
the treatment group, rhMG53 was primarily distributed 
in a limited number of  epithelial cells of  the renal tubule. 
[Figure 5].
Figure 1: Survival curve of Mitsugumin 53 (MG53)-treated and bovine 
serum albumin (BSA)-treated mice in 48 h after severe burn injury. The 
mortality of the MG53 group was lower than that of the BSA group. 
However, there was no statistically significant difference between the 
two groups (P = 0.681).
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Discussion
Scalding not only injures local tissues at the wound 
site, but also causes systemic reactions/injury to a 
certain extent. After scalding, acute ischemia/anoxia 
occurs in the organs for various reasons, e.g., early 
stress reactions, changes in vascular permeability, 
microcirculation disorders, and water/electrolyte/acid-
base imbalance.[8]
The kidney is quite sensitive to ischemia/anoxia. After 
severe scalding, body fluid is lost rapidly, which causes 
acute renal ischemia/anoxia and a series of  significant 
renal morphological changes.[9] The epithelial cells of  
the renal tubule are very vulnerable to ischemia/anoxia 
injury. Due to scald stress and early shock, the renal artery 
becomes ischemic, and the blood flow redistributes in 
the kidney, causing ischemia/anoxia in renal histocytes 
(in particular, some cells of  the renal cortex), which further 
damages the cell membrane and finally causes irreversible 
injury/death. The necrosis of  indigenous renal cells leads 
to a drop in the number of  functional renal units, further 
affecting kidney function.
Figure 2: Kidney histology in tissue from mice in either the MG53- or 
BSA-treated group (hematoxylin and eosin (HE) staining, ×400). (a) 
Healthy renal tissue. (b) Example of renal tissue from the BSA-treated 
group. Vacuolar degeneration and necrosis of kidney tubules was 
common (indicated by the arrow). (c) Example of kidney tissue from 
the MG53-treated group. These injuries were less severe than those 
observed in the BSA-treated group (indicated by the arrow). Scale bar 
denotes 100 mm. (d) Renal tissue damage scores of each group. The 
score of the MG53 group was 1.43 ± 0.19. The score of the BSA group 





Figure 5: Expression of kidney injury molecule-1(KIM-1) in mouse 
kidney in each group. MG53 immunohistochemical staining in mouse 
kidney tissues from each group (×400). (a) Endogenous MG53 is 
expressed in control muscle. (b) There is no MG53 expression in renal 
tissues. (c) Exogenous rhMG53 was not detected in renal tissue in the 
BSA-treated group. (d) Exogenous rhMG53 was detected in epithelial 
cells located in the (e) renal cortex and (f) renal medulla. Positive cells 
are indicated by the arrow. Scale bar denotes 100 mm.
a b c
d e fFigure 4: Expression of Polymerase I and transcript release factor 
(PTRF) in mouse kidney in each group. (a) PTRF immunohistochemical 
staining of mouse renal tissues in each group (×400). N1-N2 = Negative 
control group, A1-A2 = Control kidney. B1-B2 = MG53-treated kidney. 
Scale bar denotes 100 mm. (b) The mean optical density score for PTRF 
expression in each group. The score for control kidney was 313,110.9 
± 44,570.2. The score for MG53-treated kidney was 315,946.8 ± 
35,043.3. There was no statistically significant difference in mean 








Figure 3: Expression of kidney injury molecule (KIM-1) in kidney of 
mice in each group. (a) KIM-1 immunohistochemical staining of mouse 
renal tissues from each groups (×400). N1-N2 = Negative control group, 
M1-M2 = MG53-treated group, B1-B2 = BSA-treated group. Scale bar 
denotes 100 mm. (b) KIM-1 protein expression in each group. The mean 
optical density score in the MG53-treated group was significantly lower 
than that of the BSA-treated group (240,190.9 ± 58,277.4 vs 342,880.3 
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As shown in recent research, the injured cytoplasmic 
membrane can be repaired via a complex, multiple-step 
active dynamic reaction process that is mediated by MG53.[7] 
MG53 is one of  the unique muscle TRIM-family proteins, 
and it is expressed only in cardiac/skeletal muscles. It is an 
essential component of  the repair mechanism for membrane 
injury.[10] After membrane injury, MG53 receives the initial 
signal of  membrane injury (i.e., the exposure of  membrane 
lipid molecules).[7,11] Mediated by PTRF, MG53 is then 
transferred to near the injured membrane in cellular vesicles 
and is bound to the exposed membrane lipid molecules.[12,13] 
Third, the vesicles merge with the cytoplasmic membrane to 
establish the repair process.[14,15] As also shown by previous 
data, acute membrane-damage signals can be detected by 
environmental MG53 proteins that then repair the injured 
cell membrane.[2] However, MG53 cannot bind the exposed 
membrane lipid molecule by itself; thus, one mediating 
molecule is required at the injury site to anchor MG53 
to	 the	 exposed	 lipid.	PTRF	 (also	 called	 “cavin-1”)	 is	 a	
docking protein that binds MG53 at the exposed membrane 
lipid at the injury site during MG53-mediated membrane 
repair. PTRF is expressed in most organs (except the liver) 
including the kidney, lung, heart, and the skeletal muscles, 
among others.[12]
In our mouse model, we observed kidney-specific 
distribution of  exogenous rhMG53. After burn injury, 
the exogenous rhMG53 significantly alleviated damage 
to renal tissue, but not that to other internal tissues. At 
48 h after damage, histopathological analysis revealed 
milder renal injury and lower scores for renal tubule 
lesions in the MG53-treated group compared with the 
control group. KIM-1 immunohistochemical results also 
revealed a protective effect of  exogenous MG53 in the 
kidney as KIM-1 expression in the MG53-treated group 
was significantly lower than in the BSA-treated group. 
Thus, we believe that after tail vein injection, exogenous 
rhMG53 arrived selectively at the site of  injury in the 
kidney, in particular, the epithelial cells of  the renal tubule, 
and repaired the injury.
Based on immunohistochemistry, we noted that 
exogenous rhMG53 was distributed in mouse kidney 
(primarily in the epithelial cells of  the renal tubule at 
the subcapsule area and cortex-medulla interface), and 
the histopathological characteristics of  the tissue were 
significantly improved compared with the control group. 
Zhu et al., demonstrated that PTRF was expressed in 
mouse kidney, lung, heart, and skeletal muscles, and 
MG53 did not aggregate or mediate repair in the injured 
cells not expressing the endogenous PTRF.[12] Based on 
our immunohistochemistry results, we noted numerous 
PTRF+ cells in the kidney of  the injured group and there 
was no distinct difference between the injured and control 
group. Exogenous rhMG53 protein distributed in the kidney 
to areas of  high PTRF expression. However, exogenous 
rhMG53 was not distributed significantly in other tissues 
that expressed less or no endogenous PTRF. All of  the 
above results indicate that the selective distribution and 
repair mediated by exogenous MG53 correlated closely 
with PTRF.
After severe burn injury, many factors can induce multi-
tissue damage in some internal organs. As the basic 
functional unit of  the organism, cells degenerate when 
the organ is damaged, and the cell membrane is the initial 
site of  damage. MG53 is an acute membrane damage-
repair protein. MG53 can reach the membrane damage 
site quickly with other cofactors after acute damage to 
complete the injury repair. Exogenous rhMG53 protein 
injected into the tail vein selectively arrives at tissues 
where PTRF is highly expressed. Through PTRF and 
other cofactors, MG53 can repair the membrane damage 
and reduce organ injury.
In conclusion, for the first time, we show that exogenous 
rhMG53 can selectively be distributed to sites in the kidney 
that show high expression of PTRF, thereby ameliorating 
histological alterations in renal tissues after severe burn injury. 
Our	data	provide	a	novel	mechanism	for	protecting	the	kidney	
from injury that may be important for future treatment of  
burns in the clinic.
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